Need professional-grade analysis? Visit stockanalysis.com
$921.96M
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
Also Listed On
Inventiva S.A (IVEVF) Price Performance
Inventiva S.A (IVEVF) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $4.44.
Over the past year, IVEVF has traded between a low of $2.28 and a high of $4.58. The stock has gained 94.7% over this period. It is currently 94.7% above its 52-week low.
Inventiva S.A has a market capitalization of $921.96M.
About Inventiva S.A
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.
Company Info
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $16.97M
- EBITDA
- $-95,789,000
- Profit Margin
- N/A
- EPS (TTM)
- -4.42
- Book Value
- -0.07
Technical Indicators
- 52 Week High
- $4.59
- 52 Week Low
- $2.28
- 50 Day MA
- $4.44
- 200 Day MA
- $3.32
- Beta
- 0.92
Valuation
- Trailing P/E
- N/A
- Forward P/E
- -2.16
- Price/Sales
- 54.33
- Price/Book
- -59.89
- Enterprise Value
- $627.91M